Full Text View
Tabular View
No Study Results Posted
Related Studies
Acupuncture and Herbal Treatment of Chronic HIV Sinusitis
This study has been completed.
First Received: November 2, 1999   Last Updated: June 23, 2005   History of Changes
Sponsored by: Immune Enhancement Project
Information provided by: NIH AIDS Clinical Trials Information Service
ClinicalTrials.gov Identifier: NCT00002149
  Purpose

To compare Traditional Chinese Medicine versus standard antibiotic therapy consisting of pseudoephedrine ( Sudafed ) plus amoxicillin / clavulanate potassium combination ( Augmentin ) in reducing symptoms and recurrence of acute HIV-related sinusitis. Chronic sinusitis in HIV-infected individuals is a recurrent and persistent infection with potentially serious complications: it can exacerbate pulmonary disease, cause recurrences of life-threatening sepsis, and progress to central nervous system involvement. Symptoms of sinusitis in HIV patients are often refractory to aggressive Western medical management, and antibiotic intolerance can occur. Traditional Chinese Medicine consisting of acupuncture and herbal treatment may provide a low-risk, low-cost alternative to conventional antibiotic therapy.


Condition Intervention
HIV Infections
Sinusitis
Drug: Clavulanate potassium
Drug: Pseudoephedrine hydrochloride
Drug: Amoxicillin trihydrate

Study Type: Interventional
Study Design: Treatment, Parallel Assignment, Efficacy Study
Official Title: Acupuncture and Herbal Treatment of Chronic HIV Sinusitis

Resource links provided by NLM:


Further study details as provided by NIH AIDS Clinical Trials Information Service:

Estimated Enrollment: 40
Detailed Description:

Chronic sinusitis in HIV-infected individuals is a recurrent and persistent infection with potentially serious complications: it can exacerbate pulmonary disease, cause recurrences of life-threatening sepsis, and progress to central nervous system involvement. Symptoms of sinusitis in HIV patients are often refractory to aggressive Western medical management, and antibiotic intolerance can occur. Traditional Chinese Medicine consisting of acupuncture and herbal treatment may provide a low-risk, low-cost alternative to conventional antibiotic therapy.

Patients are randomized to receive either Traditional Chinese Medicine (acupuncture and herbal treatment) or conventional antibiotic therapy (Sudafed and Augmentin). Treatment continues for 8 weeks, followed by a 4 week washout, with final follow-up at week 12. Patients must undergo endoscopic nasal exam and CT scan of paranasal sinus prior to study entry and at week 12.

  Eligibility

Ages Eligible for Study:   18 Years to 60 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria

Concurrent Medication:

Allowed:

  • Antiviral medication.

Patients must have:

  • HIV infection.
  • CD4 count >= 50 cells/mm3.
  • Recurrent sinusitis.
  • No active opportunistic infection.
  • No disease progression.

Exclusion Criteria

Co-existing Condition:

Patients with the following symptoms or conditions are excluded:

  • Active infection with fever > 102 F.
  • Neurological symptoms such as epidural abscess, subdural hematoma, meningitis, and dementia.
  • Malignant neoplasm of nasal passages.
  • Not expected to remain clinically stable for the next 6 months.
  • Inability to comply with protocol requirements.
  • Malabsorption or inability to take oral medication.
  • Concurrent participation on another study where antibiotics will be used.

Concurrent Medication:

Excluded:

  • Antibiotics other than Septra.

Concurrent Treatment:

Excluded:

  • Chinese herbal medicine or acupuncture unless on that study arm.
  • Surgical intervention that has abated symptoms.

Patients with the following prior condition are excluded:

History of allergic reaction to the study antibiotics.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00002149

Locations
United States, California
Immune Enhancement Project
San Francisco, California, United States, 94114
Sponsors and Collaborators
Immune Enhancement Project
  More Information

No publications provided

Study ID Numbers: 243A
Study First Received: November 2, 1999
Last Updated: June 23, 2005
ClinicalTrials.gov Identifier: NCT00002149     History of Changes
Health Authority: United States: Food and Drug Administration

Keywords provided by NIH AIDS Clinical Trials Information Service:
AIDS-Related Opportunistic Infections
Drug Therapy, Combination
Acquired Immunodeficiency Syndrome
AIDS-Related Complex
Sinusitis
Ephedrine
Acupuncture Therapy
Drugs, Chinese Herbal
Medicine, Chinese Traditional
Drug Combinations
Antibiotics, Combined
Amoxicillin-Potassium Clavulanate Combination

Study placed in the following topic categories:
Opportunistic Infections
Anti-Infective Agents
Neurotransmitter Agents
Sexually Transmitted Diseases, Viral
Adrenergic Agents
Clavulanic Acids
Sinusitis
Nasal Decongestants
Anti-Bacterial Agents
Respiratory Tract Infections
Respiratory Tract Diseases
Phenylephrine
Clavulanic Acid
AIDS-Related Opportunistic Infections
Vasoconstrictor Agents
Retroviridae Infections
Pseudoephedrine
Amoxicillin
Otorhinolaryngologic Diseases
Acquired Immunodeficiency Syndrome
Anti-Asthmatic Agents
Central Nervous System Stimulants
AIDS-Related Complex
Cardiovascular Agents
Amoxicillin-Potassium Clavulanate Combination
Immunologic Deficiency Syndromes
Virus Diseases
Oxymetazoline
HIV Infections
Sexually Transmitted Diseases

Additional relevant MeSH terms:
Respiratory System Agents
Anti-Infective Agents
Neurotransmitter Agents
Sexually Transmitted Diseases, Viral
Slow Virus Diseases
Molecular Mechanisms of Pharmacological Action
Adrenergic Agents
Paranasal Sinus Diseases
Physiological Effects of Drugs
Clavulanic Acids
Sinusitis
Infection
Nasal Decongestants
Anti-Bacterial Agents
Respiratory Tract Diseases
Respiratory Tract Infections
Therapeutic Uses
Clavulanic Acid
Vasoconstrictor Agents
Retroviridae Infections
Pseudoephedrine
RNA Virus Infections
Amoxicillin
Otorhinolaryngologic Diseases
Immune System Diseases
Sympathomimetics
Acquired Immunodeficiency Syndrome
Anti-Asthmatic Agents
Enzyme Inhibitors
Central Nervous System Stimulants

ClinicalTrials.gov processed this record on September 02, 2009